Skip to content

Orange Book Blog

At the intersection of Patent and FDA Law

About
Authors
Disclaimer

Recent Posts

A note on ANDA settlement agreements
Hikma v. Vanda: Oral Argument Recap
Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
Should ANDA filers be using the PTAB to mount early challenges to OB patents?
Switching to WordPress

Twitter
Facebook
Instagram

Switching to WordPress

September 30, 2025

TypePad has shut down on us, so we’re moving the blog to WordPress. Thank you for your patience as we learn how to navigate this new blog!

Share this:

X
Facebook

Like Loading…

Posted in Uncategorized

Leave a comment Cancel reply

Δ

←Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases

Should ANDA filers be using the PTAB to mount early challenges to OB patents?→

Blog at WordPress.com.

Comment
Reblog
Subscribe Subscribed
- Orange Book Blog
- Already have a WordPress.com account? Log in now.

%d